Propanc Biopharma, Inc.

PPCB ·Healthcare, Drug Manufacturers - General, Australia

← 5Y 10Y MAX →

Returns on Capital

ROE ROI ROA

Period	ROE	ROI	ROA
Dec 2011	-60.0%	-60.0%	-55.7%
Mar 2012	-184.7%	-184.7%	-143.4%
Jun 2012	474.3%	474.3%	-5,514.8%
Sep 2012	80.8%	80.8%	-1,819.0%
Dec 2012	60.3%	60.3%	-3,152.5%
Mar 2013	45.2%	45.2%	-8,160.3%
Jun 2013	28.3%	28.3%	-12,852.4%
Sep 2013	46.9%	46.9%	-1,476.1%
Dec 2013	-2.5%	-2.5%	221.4%
Mar 2014	5.7%	5.7%	-167,162.5%
Jun 2014	15.5%	15.5%	-191.3%
Sep 2014	43.9%	43.9%	-1,518.8%
Dec 2014	18.4%	18.4%	-652.6%
Mar 2015	24.5%	24.5%	-146.7%
Jun 2015	59.9%	59.9%	-291.8%
Sep 2015	26.4%	26.4%	-274.9%
Dec 2015	106.1%	106.1%	-236.2%
Mar 2016	61.1%	61.1%	-132.6%
Jun 2016	111.4%	209.7%	-753.7%
Sep 2016	61.1%	61.1%	-607.5%
Dec 2016	97.9%	97.9%	-2,768.7%
Mar 2017	29.1%	66.5%	-3,061.5%
Jun 2017	30.0%	83.3%	-1,718.2%
Sep 2017	28.6%	92.3%	-1,183.8%
Dec 2017	30.8%	80.6%	-1,705.9%
Mar 2018	22.0%	66.0%	-1,346.3%
Jun 2018	21.1%	69.3%	-1,992.6%
Sep 2018	38.2%	118.1%	-2,567.1%
Dec 2018	37.1%	130.1%	-203.5%
Mar 2019	17.0%	43.3%	-223.9%
Jun 2019	37.2%	60.6%	-1,575.5%
Sep 2019	32.8%	74.8%	-754.8%
Dec 2019	32.9%	68.2%	-2,853.8%
Mar 2020	53.3%	121.1%	-4,044.0%
Jun 2020	-33.1%	-57.8%	1,222.1%
Sep 2020	13.2%	19.3%	-548.7%
Dec 2020	11.2%	16.8%	-993.8%
Mar 2021	13.9%	20.3%	-1,489.6%
Jun 2021	25.4%	31.9%	-5,946.3%
Sep 2021	21.3%	28.5%	-789.3%
Dec 2021	27.3%	40.9%	-726.1%
Mar 2022	15.7%	24.7%	-273.0%
Jun 2022	29.9%	43.1%	-1,108.1%
Sep 2022	22.3%	33.3%	-654.9%
Dec 2022	16.7%	16.7%	-449.4%
Mar 2023	27.5%	33.4%	-563.4%
Jun 2023	24.0%	27.4%	-1,240.0%
Sep 2023	11.7%	13.5%	-194.5%
Dec 2023	16.4%	20.3%	-241.6%
Mar 2024	14.2%	16.9%	-1,410.7%
Jun 2024	9.5%	10.6%	-495.5%
Sep 2024	8.6%	9.5%	-556.7%
Dec 2024	10.3%	11.5%	-547.8%
Mar 2025	-298.8%	-291.8%	-240.0%
Jun 2025	-29.3%	-28.2%	-20.7%
Sep 2025	-33.7%	-33.4%	-26.9%
Dec 2025	-29.6%	-29.4%	-20.5%
Mar 2026	-64.7%	-64.4%	-44.4%
Jun 2026	-48.6%	-48.6%	-35.8%